Hepcidin, the key regulatory hormone of iron homeostasis, and iron carriers such as transferrin receptor1 (TFR1), divalent metal transporter1 (DMT1), and ferroportin (FPN) are expressed in kidney. Whether hepcidin plays an intrinsic role in the regulation of renal iron transport is unknown. Here, we analyzed the renal handling of iron in hemochromatosis Hepc À / À and Hjv À / À mouse models, as well as in phenylhydrazine (PHZ)-treated mice. We found a marked medullary iron deposition in the kidneys of Hepc À / À mice, and iron leak in the urine. The kidneys of Hepc À / À mice exhibited a concomitant decrease in TFR1 and increase in ferritin and FPN expression. Increased FPN abundance was restricted to the thick ascending limb (TAL). DMT1 protein remained unaffected despite a significant decrease of its mRNA level, suggesting that DMT1 protein is stabilized in the absence of hepcidin. Treatment of kidney sections from Hepc À / À mice with hepcidin decreased DMT1 protein, an effect confirmed in renal cell lines where hepcidin markedly decreased 55 Fe transport. In the kidneys of Hjv À / À mice exhibiting low hepcidin expression, the iron overload was similar to that in the kidneys of Hepc À / À mice. However, in PHZ mice, iron accumulation resulting from hemoglobin leak was detected in the proximal tubule. Thus, kidneys exhibit a tissue-specific handling of iron that depends on the extra iron source. Hepcidin may control the expression of iron transporters to prevent renal iron overload.
Iron has an essential function in renal metabolism. Indeed, the efficiency of kidney to produce hemoproteins (e.g., cytochrome P450) depends on both the ability to acquire iron and to synthesize heme, the iron-containing tetrapyrrole ring. Acquisition of iron by kidney is assumed to be from circulation through ubiquitous transferrin receptor1 (TFR1), because plasma iron is tightly bound to transferrin, a 78-kDa circulating protein that was assumed to not cross the glomerulus filter. However, increasing data describing the presence of iron transporters, especially divalent metal transporter1 (DMT1) at the apical 1 and ferroportin (FPN) at the basolateral membrane of the renal tubular cells 2 suggest that kidney, in addition to a selfsupply, should undertake an iron reabsorption and contribute to general iron homeostasis. Iron reabsorption was indeed observed by Wareing's group using in vivo micropuncture techniques. 3 Moreover, more recent evidence derived from animal models 4 and pathological conditions 5, 6 suggest that transferrin may be filtered by the glomerulus, and that transferrin-bound iron is reabsorbed all along the proximal tubule following endocytosis via the megalin-cubilin pathway 4 and TFR1, also found at the apical membrane of the proximal tubule. Iron homeostasis relies mainly on the control of iron efflux from duodenal enterocytes and from macrophages after the phagocytosis and degradation of senescent red blood cells and heme catabolism. 7 Hepcidin, which is synthesized by hepatocytes, is the main regulator of these iron fluxes. Hepcidin binds to FPN, the sole iron exporter in mammalian cells, and limits iron efflux. 8 In duodenal enterocytes, we recently showed that hepcidin reinforces the control over iron absorption by additionally downregulating apical DMT1. 9 Hepcidin synthesis is regulated by iron. This regulation is complex and involves hemochromatosis proteins present at the plasma membrane of the liver, i.e, high Fe gene, transferrin receptor 2, and the BMP coreceptor hemojuvelin (HJV). 10 Increased hepcidin gene expression following iron overload involves tightly coordinated signaling through the high Fe gene/transferrin receptor 2 and BMP/HJV/SMAD pathways.
Gene alteration of these hemochromatosis proteins underlies most genetic forms of iron overload characterized by iron loading of the parenchyma and depletion of macrophage iron stores. Late-onset adult hemochromatosis results from mutations in the high Fe gene protein. 11 Both hepcidin and HJV mutations are responsible for the rare juvenile forms of hemochromatosis with heavy iron overload. Hemochromatosis gene knockout mice were shown to reproduce the human hemochromatosis phenotype. Indeed, the Hfe À / À mouse model showed only moderate iron overload, whereas Hjv À / À and Hepc À / À models have a severe iron overload because of the pronounced alteration of hepcidin gene expression.
Although a recent finding showed that plasma hepcidin is highly bound to the protein carrier a2-macroglobulin to prevent massive clearance, 12 this low-molecular-weight hormone is still assumed to be rapidly filtered, taken up, and degraded by the proximal tubule of the kidney. 13, 14 A lack of hepcidin clearance by the altered kidneys was recently considered, in addition to inflammation, to increase plasma hepcidin concentrations in patients with chronic kidney diseases and to potentiate anemia in these patients. 15 Furthermore, it has been shown that hepcidin is locally synthesized and secreted within renal tubules. 16, 17 However, the role of this local synthesis is not yet defined.
Here, we aimed to explore the intrinsic iron handling of kidney and to determine the role of hepcidin in renal iron metabolism. We used Hepc À / À and Hjv À / À hemochromatosis models, in addition to PHZ-treated mice used as a model of acute hemolysis. PHZ mice are characterized by hemoglobin wasting with secondary iron overload and decreased hepcidin expression in the liver. 18 
RESULTS

Parameters of iron status in Hepc
Biochemical markers of iron status were studied in the serum of 12-week-old Hepc À / À mice. Serum ferritin and transferrin saturation were highly elevated in the knockout mice compared with their wild-type littermates (Figure 1a) , reminiscent of what is observed in humans. Iron overload in this model was associated with a significant leakage of non-heme iron in the urine (Figure 1b) . Toxicity of iron on renal function was evaluated by the measurement of both serum urea level and creatinine clearance calculations. Hepc À / À mice had normal kidney function compared with control mice (Supplementary Data S1 online).
Localization of iron deposits in the kidney
By Perl's staining, iron overload in Hepc À / À kidneys was mainly located in the medulla and in a few cortical tubules (Figure 2 ). At higher magnification, iron could also be observed in the lumen of the distal part of the nephron (Figure 2 ). However, there was no iron accumulation within the collecting duct (CD), identified by its principal and intercalated cells. There was no iron deposition in the proximal tubule or in the glomerulus, suggesting that iron overload occurs only in specific tubules of the distal nephron in this model.
Expression and localization of FPN in the kidney
The mRNA level of FPN was not modified in Hepc À / À mice compared with control mice, neither in the cortex nor in the medulla (Figure 3a) . However, the FPN protein abundance, which was almost undetectable in control mice, was significantly increased in both kidney subregions of Hepc À / À mice ( Figure 3b ). FPN induction was much more robust in the medulla than in the cortex. We then analyzed the tubular distribution of FPN by immunofluorescence (Figure 3c ). In control mice, renal FPN staining was close to background level, confirming low basal expression. In Hepc À / À mice, FPN signal was very strong, with maximal staining in the medulla, particularly in the outer strip. FPN fluorescence was also observed in some cortical tubules, strengthening the correlation between FPN expression and iron deposition in the kidney of this model. The tubular and subcellular locations of FPN was identified by colocalization studies using consecutive serial sections and antibodies specific for apical markers of renal tubules, e.g., lectin Lotus tetragonolobus, Tamm-horsfall (THP), and aquaporin 2 for the proximal tubules, TALs of the loop of Henle, and CDs, respectively. The FPN signal was completely colocalized with THP staining, indicating FPN induction in the TALs of the loop of Henle (Figure 4) . Furthermore, within these cells, THP and FPN signals were differentially located, as THP was observed in the apical membrane, whereas FPN was observed in the basolateral membrane and intracellularly. FPN immunofluorescence was not detected in lectin Lotus tetragonolobusstained proximal tubules or in aquaporin 2-positive CD tubules. The aforementioned data showed that FPN expression correlates with iron accumulation within the TALs.
Expression of TFR1 and DMT1 in the kidney Figure 5 showed significant decreases in the mRNA expression of TFR1 and DMT1 in the cortex and medulla of Hepc À / À mice. The decreased TFR1-mRNA level was accompanied by a large diminution of TFR1 protein abundance. However, no change in the protein expression of DMT1 was observed, suggesting that DMT1 must undergo translational or post-translational upregulation to oppose the decrease in its mRNA expression. Thus, DMT1 fails to adapt to the extra-influx of iron in the Hepc À / À kidney. We previously showed that hepcidin induces the degradation of DMT1 in duodenal enterocytes. 9 Therefore, we hypothesized that treatment of Hepc À / À kidney slices with hepcidin may drastically reduce DMT1 protein abundance, as the level of DMT1 transcript in this model is already decreased. Indeed, the incubation of Hepc À / À kidney slices with hepcidin for 4 h resulted in significant decreases of DMT1 protein levels ( Figure 5b2 ). We also observed a decrease of DMT1 in wild-type kidney slices after hepcidin treatment (Figure 5b2 ), but this effect was not significant owing to the unexpected heterogeneity of the responses in this group. It is interesting to note that FPN expression was not affected in the kidney slices treated with hepcidin, which was similar to that observed in duodenal enterocytes 9 (Supplementary Data S2 online).
Iron transport in opossum kidney (OK) cells. To obtain further insights into the mechanism of hepcidin-induced downregulation of renal DMT1, we performed in vitro studies using OK cells, a line that conserves several renal tubular properties and is commonly used to study renal ion transport and regulation. We studied 55 55 Fe uptake by OK cells (see Materials and Methods) was also inhibited with hepcidin treatment (Figure 6b ). Iron transport activity was repressed in a concentration-dependent manner. A significant inhibitory effect was observed at 50 nmol/l hepcidin and became maximal at 200 nmol/l (Figure 6c ), a concentration that led to the maximal inhibition of iron transport in the intestine. 9 We then studied the hepcidin-induced internalization of DMT1 by immunofluorescence. Figure 7a shows that OK cells transfected with the DMT1-( þ IRE)-GFP plasmid displayed intrinsic fluorescence of the enhanced green fluorescent protein-fused DMT1 in the plasma membrane, predominantly the apical surface, and in the endosomal vesicles. Enhanced green fluorescent protein-coupled DMT1 was internalized upon treatment with 200 nmol/l hepcidin, as observed by the membrane retrieval and then disappearance of the green fluorescence in the first 2 h of incubation of the cells. This effect was maintained up to 4 h of incubation. These data indicate that iron reabsorption by the kidney is inhibited by hepcidin, and that DMT1 is a target for the hormone.
We tried to confirm these data in another cell line derived from the TAL of the loop of Henle, e.g., TAL cells. In these cells, GFP-fused DMT1 exhibited an apical location, with predominance in endosomal vesicles (Supplementary Data S3 online). The 55 Fe transepithelial transport in these cells was at least 20-fold lower than that of OK cells. Treatment with hepcidin resulted in a decrease in both transepithelial transport and cellular uptake of 55 Fe, but this effect was also very modest compared with that observed in OK cells (Supplementary Data S4 online). This discrepancy may be due to endogenous synthesis of hepcidin in TAL cells. Indeed, OK cells originate from the proximal nephron, whereas TAL cells are derived from the distal nephron where hepcidin is known to be synthesized. 17 Indeed, reverse transcriptionquantitative PCR experiments showed a significant production of hepcidin in TAL cells (ct ¼ 24 vs. ct ¼ 15 for hepcidin and glyceraldehyde 3-phosphate dehydrogenase, respectively).
Renal handling of iron in other mouse models of iron overload. The data above suggest that hepcidin controls renal iron handling. Hepcidin in the kidney could either be derived from circulation, plasma filtration, or be produced by tubular cells. To investigate the possible involvement of intrarenal hepcidin in renal iron handling, we compared iron distribution and renal hepcidin synthesis between hemochromatosis models Hjv À / À and Hepc À / À and PHZ-treated mice as a model of acute hemolysis (Figure 8) .
By performing Perl's staining, we found that in Hjv À / À mice iron overload was moderately intense, but its pattern was similar to that observed in Hepc À / À mice. However, in PHZ-treated mice, the phenotype of iron overload was very different after cortical iron accumulation, most certainly resulting from hemoglobin filtration into the urine. Iron accumulated in the brush border-specific proximal tubules. The tissue-specific iron accumulation in the kidney in the different models was confirmed by the concomitant increase in ferritin and FPN protein expression in all of the regions where excess iron deposition was detected (Figure 8b ). Extrarenal iron overload was verified by the study of iron balance parameters (Supplementary Data S5A online). Urinary iron wasting was observed in both Hjv À / À and PHZ-treated mice (Supplementary Data S5B online).
We then analyzed renal hepcidin synthesis by quantitative reverse transcription-quantitative PCR. To validate the experiments, liver RNA was systemically used as a positive control, and RNA from Hepc À / À kidneys (where hepcidin is fully absent) was used as a negative control. Figure 8c revealed a clear decrease in hepcidin mRNA expression in the medulla of Hjv À / À mice. In PHZ mice, where iron deposits were observed in the cortex but not in the medulla, hepcidin mRNA expression remained unchanged compared with control mice. Table 1 summarizes the data obtained between all the mouse models used.
DISCUSSION Filtered plasma iron is taken up in the distal nephron
Our data indicate that there is a cell specificity of iron handling in the kidney, which depends on the pathological origin of the iron overload. To our knowledge, this is the first study to demonstrate an in vivo modulation of iron content in the medulla and a significant regulation of iron carriers at this site.
Until recently, the proximal tubule was thought to be the preferential site of iron uptake, as it possesses the machinery required for this reabsorption. In particular, the proximal tubule expresses TFR1, DMT1, and cubulin/megalin complexes at the luminal pole, as well as FPN in the basolateral membrane. Indeed, in our hemolytic mice (PHZ mice), iron accumulated in the proximal tubule, as was previously described, 17 probably as a result of a massive uptake of urinary hemoglobin by the cubulin/megalin complex and degradation of heme by heme-oxygenase (HO-1). However, in both Hepc À / À and Hjv À / À hemochromatosis models, iron deposition and increased FPN expression were only observed in the distal nephron, without any modification in the proximal tubule, suggesting that iron is taken up solely by the distal nephron. Plasma iron in these hemochromatosis models is high, and transferrin is fully saturated (Figure 1 and Supplementary Data S5 online); however, we postulate that because of the high acidic pH in the tubular lumen iron must be rapidly dissociated from filtered transferrin and routed to the distal segments, where it is transported by DMT1. There is another possible transferrin-independent source of iron overload in the kidney. When serum iron exceeds the iron-binding capacity of transferrin, iron can be found as non-transferrinbound iron, which is taken up efficiently by cells. Circulating non-transferrin-bound iron is supposed to be mostly bound to citrate and albumin; 19 both are filterable by the glomerulus and reabsorbed in the proximal tubule. 19, 20 However, the accumulation of iron in the distal kidney does not support this hypothesis unless the non-transferrin-bound iron undergoes, as does transferrin, changes in the acidic environment and releases iron into distal segments.
Interestingly, the CD was spared, with no detection of iron by Perl's staining and no detectable expression of FPN in the colocalization studies, despite a massive flow of iron into the urine. This is an interesting finding that suggests that the CD is not involved in urinary iron handling. We speculate that, considering the vulnerability of the CD toward pathogen invasions when it is confronted with a urinary tract infection, this renal tubule must have a robust barrier to limit iron entry within cells and therefore to prevent bacterial development. Additional studies are in progress in our laboratory to explore this hypothesis.
FPN is overexpressed in the TALs of the loop of Henle (TAL)
We found that overexpression of FPN protein was specifically located in the distal nephron where iron was accumulated. Moreover, FPN showed basolateral sorting with specific induction in the TAL. Basolateral localization of FPN in the renal nephron has already been described in the cortex and outer medulla. 2, 17 Our data differ from those studies by the fact that under basal conditions we observed only a weak immunostaining of FPN, which was insufficient to study the expression pattern of FPN along the nephron. Differences in the sensitivity of the FPN antibodies could account for these discrepancies. In our study, FPN was barely detectable by immunostaining or western blotting when using either a commercial antibody or an antibody that was kindly provided by D. Haile. 21 Basal FPN expression may then differ between mouse strains (129Sv and C57BL6 vs. CF1 in Veuthey et al. 17 ) and/or species (mouse vs. rat in Wolff et al. 2 ). The accumulation of iron in the TAL despite a high level of FPN expression is surprising. However, it is possible that the incoming iron stimulates ferritin, thereby favoring iron retention within the cells rather than FPN-mediated export, even more so in the absence of free iron-binding sites on the almost fully saturated plasma transferrin in both Hepc À / À and Hjv À / À mice. FPN mRNA contains an iron responsive element (IRE) in its 5 0 -untranslated region, which is responsible for ironmediated translational regulation of FPN by the iron regulatory proteins (IRP1 and 2). [21] [22] [23] [24] These IRPs are both expressed in the kidney 25 and may stimulate FPN expression following increased iron deposition. This IRE/IRP system is probably also responsible for the increased ferritin synthesis and reduced TFR1 mRNA in kidney subregions where iron accumulated. FPN expression may also increase in response to hepcidin loss in our models. However, data from ex vivo experiments on kidney slices (Supplementary S2 online) showed that FPN protein remained insensitive to exogenous hepcidin treatment, which was similar to that observed in the duodenal epithelium. 9 Hepcidin may regulate DMT1 in the kidney Another notable finding in our study is the hepcidinmediated regulation of the DMT1 cotransporter. Results from the Hepc À / À model and from cell lines show that DMT1 is regulated at both the mRNA and protein levels, but in opposite ways. DMT1 mRNA was decreased in a similar manner as the housekeeping TFR1 mRNA ( Figure 5 ) probably by the IRE/IRP system, which is known to act simultaneously on both TFR1 and DMT1 transcripts. Indeed, both IRE-containing and non-IRE forms of DMT1 mRNA are present in the kidney. 26 These data are in accordance with those of Smith's group, who showed in rats that renal DMT1 protein expression is repressed following a high-iron diet. 27 However, in our Hepc À / À model that lacked hepcidin, the protein level of DMT1 was not modified, suggesting a posttranscriptional regulation of the DMT1 protein that compensates for the reduced mRNA levels. Thus, in the kidney, hepcidin appears to be another mechanism that downregulates DMT1 at the protein level. We confirmed this hypothesis by investigations of Hepc À / À kidney slices in which DMT1 protein abundance was clearly reduced following exogenous hepcidin treatment (Figure 5b2 ). Studies on OK and/or TAL cells where transepithelial transport of iron was inhibited by physiological concentrations of hepcidin ( Figures 6 and 7 and Supplementary S3 and S4 online) demonstrated that this reduction is due to the internalization and degradation of the DMT1, which was similar to that shown in the intestine. 9 Thus, our results show that a functional transepithelial transport of iron in the distal nephron takes place, but that this transport is highly inhibited by hepcidin. The physiological role of this transport and its regulation remain to be determined.
Is hepcidin synthesized by kidney implicated in the control of renal handling of iron?
Mass spectroscopy studies have shown that urinary hepcidin exists in the native, bioactive 25-amino-acid form, as well as in the shorter, nonfunctional 22-and 20-amino-acid forms. 28 It is not known whether this urinary hepcidin contributes to the control of renal handling of iron. In addition, tubular cells have been shown to synthesize hepcidin, especially in the TAL. 16, 17 These regions of the nephron that synthesize hepcidin also happen to be the regions where we found extra iron deposits in mice lacking hepcidin synthesis. Interestingly, the degree of kidney iron overload seemed to correlate with the extent of hepcidin synthesis in kidney tubules rather than with the extent of systemic iron overload. In PHZ-treated mice, no excess iron was observed in the distal nephron, and kidney hepcidin mRNA levels were normal. However, in both Hepc À / À and Hjv À / À mice, there was a good correlation between renal iron overload and the degree of hepcidin mRNA repression. Therefore, it is tempting to speculate that, in these cells, hepcidin regulates iron transport in an autocrine manner, similar to what has been described in macrophages 29 and parietal cells. 30 It is possible that the native 25-amino-acid hepcidin found in urine derives from renal cells, whereas the shorter forms are degradation products derived from the filtration of plasma hepcidin. Interestingly, it has been suggested that serum levels of the 25-amino-acid hepcidin are not dependent on the estimated glomerular filtration rate in patients with chronic kidney disease. 31 Together, our results highlight a new role of hepcidin in the control of renal iron transport and accumulation. As summarized in Figure 9 , hepcidin seems to specifically target the distal nephron rather than the proximal tubule. As it is also an antimicrobial peptide, the local synthesis of hepcidin in the distal nephron may represent an effective defense system against infections. Our data also emphasize the involvement of the kidney in the control of urinary iron in pathological situations, such as hemochromatosis and hemolytic anemia, and suggest that the measurement of the different hepcidin isoforms using mass spectroscopy would be very beneficial for the study of renal diseases.
MATERIALS AND METHODS Animals
All animals were of the 129Sv genetic background. HJV knockout animals were a kind gift from Nancy Andrews (Duke University, Durham, NC).
For acute hemolysis, 10-week-old mice were intraperitoneally injected with PHZ (40 mg/kg, Sigma-Aldrich, Chemie S.a.r.l., SaintQuentin Fallavier, France) everyday for 2 weeks. Hemolysis was verified, and only anemic mice were retained for further analysis.
Biochemical analyses
Urine was collected from individual mice that were maintained in metabolic cages. Serum and urine non-heme iron, ferritin, and transferrin levels were measured using an AU400 automate (Beckman Coulter France S.A.S., Villepinte Roissy, France).
Slices, cortex, and medulla tissue preparation
The kidneys of anesthetized mice were rapidly removed after perfusion through the left ventricle with Hank's solution (pH 7.4, 37 1C). They were immediately immersed into ice-cold Hank's solution and cut into thin cortico-papillary slices. The sections were equilibrated during 10 min at 37 1C and 5% CO 2 /95% O 2 and then treated with 200 nmol/l hepcidin or vehicle (H 2 O) for 4 h. They were then immediately immersed in liquid nitrogen, and stored at À 80 1C. For cortex and medulla tissue preparations, the sections were excised through a piece of nylon tissue and rapidly frozen and stored at À 80 1C.
Electrophoresis and immunoblotting
Total proteins were prepared as described in Brasse-Lagnel et al. 9 For western blot analysis, 10-60 mg of proteins was separated on a 10-12% SDS-polyacrylamide mini-gel and transferred to nitrocellulose membranes (Mini Trans Blot Module, Bio-Rad, Marnes-la-Coquette, France). Primary antibodies were used at 1:6000 dilutions for anti-FPN (a kind gift from Dr D Haile, San Antonio, TX), 1:1000 for anti-TFR1 (Life Technologies, SAS Saint Aubin, France), 1:1000 for anti-H-ferritin (a kind gift from Paolo Arosio, Brescia, Italy), 1:500 for anti-DMT1 (Abcam, Paris, France), and 1:10,000 for anti-b-actin (Sigma-Aldrich Fine Chemicals). The immunoreactive bands were revealed with the ECL kit and quantified using the NIH Image software. The results of the band densities are expressed relative to b-actin.
Immunohistochemical methods
The kidneys were fixed in 4% formaldehyde, embedded in paraffin, and sections of 4-mm were then stained with Perls' Prussian blue to Quantitative reverse transcription-PCR Total RNA was isolated using the SV Total RNA isolation kit (Promega, Lyon, France) according to the manufacturer's instructions. The reverse transcription reaction was performed using 2 mg of total RNA in a final volume of 20 ml. Real-time PCR was performed in duplicate in a Light Cycler II LC 480 (Roche Diagnostics, Maylan, France) using the SYBR Green PCR-mix (Roche) and specific primers for DMT1 ( þ IRE and À IRE isoforms combined). Glyceraldehyde 3-phosphate dehydrogenase was used as a housekeeping gene (Supplementary Data S5 online). Standard curves were generated by serial dilution of the reverse transcription for all genes tested. The quantity of all mRNAs was calculated relative to the appropriate standard curve using the Light Cycler 480 software SW1-5 (Roche Diagnostics). The abundance of all mRNAs was normalized to the amount of glyceraldehyde 3-phosphate dehydrogenase transcript after validation by the GeNorm software (Biogazelle, Gent, Belgium).
Cell cultures, iron transport, and videomicroscopy OK cells (ATCC, LGC Standards, France) were cultured in DMEM/ Ham's F12 medium (1:1, vol:vol) supplemented with 10% defined fetal bovine serum (Hyclone, Perbio Science, Brebières, France), 2 mmol/l glutamine, 20 mmol/l 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, and penicillin/streptomycin (0.1 U/l, 0.1 mg/l) under a 5% CO 2 -containing atmosphere. Mouse TAL cell lines (nice gift from Pr Glenn T. Nagami, USA) were grown in DMEM/Ham's F12 medium (1:1) supplemented with 7% defined fetal bovine serum, 5 nmol/l sodium selenite, 0.03 nmol/l insulin, 12 mmol/l 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 35% O 2 , and 5% CO 2 .
For iron transport studies, cells were grown on Transwell membrane inserts (Corning, New York, NY). At confluence, cells were deprived of serum for 24 h and then treated by adding 25-amino-acid synthetic hepcidin (Peptides International, Louisville, KY) or vehicle (H 2 O) to the basolateral side of the monolayer. After 4 h of incubation, the cells were used for iron transport studies as described in detail by Lagnel et al. 9 Briefly, the apical medium was replaced by a transport solution (Hank's balanced salt solution (pH 6.5) containing 10 nmol/l iron as a mixture of 55 FeCL 3 (10 mCi/ml; Perkin Elmer, Boston, MA) and Fe-NTA (1:4, mol/mol)), and the radioactivity of the basolateral medium was detected by liquid scintillation spectroscopy (liquid scintillation analyzer TMI-CARB 2300 TR, Canberra France, Saint Quentin en Yvelines, France). To assess 55 Fe uptake, the cells were rinsed twice with PBS and solubilized with 200 ml of RIPA buffer (50 mmol/l Tris, pH 8, 150 mmol/l NaCl, 1% Triton X-100, 0.1% SDS), and the radioactivity of the cell lysate was detected by liquid scintillation. Iron transport activity and uptake were evaluated as a ratio of counts per minute per milligram of total protein. All measurements were performed in triplicate.
For videomicroscopy experiments, living fluorescent cells expressing DMT1-( þ IRE)-enhanced green fluorescent protein were selected before treatment with an epifluorescence microscope (LEICA DM-IRM, Leica Microsystèmes SAS, Nanterre, France) equipped with a humidified chamber (5% CO 2 , 37 1C). Hepcidin or vehicle was then added to the medium, and the fluorescent emission was acquired using the Zeiss LSM Image Browser software (Carl Zeiss SAS, Le Pecq, France).
Statistical analysis
The results are expressed as the means ± s.e.m.. Statistical significance between experimental groups was assessed by the Student's unpaired t-test, as appropriate.
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